|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2008-3-14
|
|
pubmed:abstractText |
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) have been widely used in clinical practise and their efficacy in reducing cardiovascular risk has been well described.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Fatty Acids, Monounsaturated,
http://linkedlifedata.com/resource/pubmed/chemical/Hydrogen Peroxide,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA...,
http://linkedlifedata.com/resource/pubmed/chemical/Indoles,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Small Interfering,
http://linkedlifedata.com/resource/pubmed/chemical/TRPM Cation Channels,
http://linkedlifedata.com/resource/pubmed/chemical/TRPM2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/fluvastatin
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1538-7836
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
692-700
|
|
pubmed:meshHeading |
pubmed-meshheading:18221360-Antibodies, Monoclonal,
pubmed-meshheading:18221360-Apoptosis,
pubmed-meshheading:18221360-Cell Division,
pubmed-meshheading:18221360-Cells, Cultured,
pubmed-meshheading:18221360-DNA Damage,
pubmed-meshheading:18221360-Endothelial Cells,
pubmed-meshheading:18221360-Fatty Acids, Monounsaturated,
pubmed-meshheading:18221360-Genes, bcl-2,
pubmed-meshheading:18221360-Humans,
pubmed-meshheading:18221360-Hydrogen Peroxide,
pubmed-meshheading:18221360-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:18221360-Indoles,
pubmed-meshheading:18221360-Necrosis,
pubmed-meshheading:18221360-Oxidative Stress,
pubmed-meshheading:18221360-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:18221360-RNA, Small Interfering,
pubmed-meshheading:18221360-TRPM Cation Channels,
pubmed-meshheading:18221360-Umbilical Veins,
pubmed-meshheading:18221360-Up-Regulation
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Fluvastatin reduces oxidative damage in human vascular endothelial cells by upregulating Bcl-2.
|
|
pubmed:affiliation |
Postgraduate Medical Institute and Hull York Medical School, University of Hull, Hull, UK. s.xu@hull.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
